Stem Cell Banking Market By Source Type (Cord Blood and Cord Tissue), By Service Type (Collection and Transportation, Processing, Analysis, and Storage), By Application (Leukemia, Diabetes, Lymphoma, Cerebral Palsy, Thalassemia, and Others), and By Region- Trends, Analysis and Forecast till 2034

Stem Cell Banking Market accounted for US$ 6.3 Billion in 2024 and is estimated to be US$ 16.3 Billion by 2034 and is anticipated to register a CAGR of 11.0%.

Stem cells are the highly specialized body cells working as a foundation cells for organ and tissue in the body. The birth of a child is the only chance to collect as well as store these stem cells which can be used to treat various diseases. The stem cells have the ability to rebuild or regenerate themselves. Stem cells are also known as building blocks of the immune system and blood, as they help to repair tissues, organs, and blood vessels. Stem cells found in umbilical cord blood have been used in treating diseases like sickle cell disease, leukemia, multiple myeloma, lymph proliferative disorders, and SCID. 

                     For More Report Details, Download Free Sample PDF

Growing awareness regarding therapeutic potential of stem cells

Growing awareness regarding therapeutic potential of stem cells is key factor driving growth of the stem cell banking market. Additionally, growing developments of novel technologies for stem cell preservation, processing, and storage is supporting factor propelling growth of the target market.

Rising hematopoietic stem cell transplantation procedures, coupled with increasing investments in stem cell-based research are major factors expected to fuel growth of the stem cell banking market over the forecast period. However, a high cost of stem cell banking is key factor for restraining growth of the stem cell banking market.

Stem cell banking market is segmented on the basis of source type, service type, application, and region.

On the basis of source type, the stem cell banking market is segmented into cord blood and cord tissue. On the basis of service type, the target market is classified into collection and transportation, processing, analysis, and storage. On the basis of application, the stem cell banking market is bifurcated into leukemia, diabetes lymphoma, cerebral palsy, thalassemia, and others.

Regional Insights:

On the basis of region, the stem cell banking market has been segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. The market in North America is expected to account for a major revenue share in the global market as compared to that of other regions. This can be attributed to the availability of federal funding for stem cell research and the rise in preference for private stem cell banking in the countries of the region. Also, the market in Europe is expected to account for the second-highest revenue share in the global market, followed by the market in Asia Pacific.

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the stem cell banking market report based on Source Type, Service Type, End User and Region.

Key players operating in the stem cell banking market includes Cryo-cell International, Inc., Stem Cyte, Inc., ViaCord, Inc., Cord Blood Registry , Inc., SmartCells, Inc., LifeCell International Pvt.Ltd, Cryoviva Biotech Pvt. Ltd., Cryo Stemcel Private Limited, Reliance Life Sciences Private Limited, and Trascell Biolife Pvt. Ltd.

Recent Development:

 The New Launched Product News,

• In July 2023, Cell Genesis announced the launch of CEXCI Cord Protein Banking, a groundbreaking initiative that marks a new era in the field of stem cell research and personalized medicine. This innovative approach harnesses the power of umbilical cord stem cells protein to unlock a world of possibilities for improved health outcomes and transformative medical treatments.
• In November 2023, LifeCell, India's largest and most accredited stem cell banking company announced the launch of world's most affordable stem cell banking solution. Aishwarya Rai Bachchan, a patron of LifeCell and goodwill ambassador for stem cell banking reinforced the value of stem cell banking on the occasion of 25th anniversary year of stem cell treatments and stated this as the best gift parents can give for their child.

• CDI laboratories
• Cryo-cell International
• Stem Cyte, Inc.
• ViaCord
• Cord Blood Registry
• SmartCells, Inc.
• LifeCell International Pvt.Ltd
• Cryoviva Biotech Pvt. Ltd
• Cryo Stemcell
• Reliance Life Sciences
• Trascell Biolife Pvt. Ltd